P&amp;G presses for OK on sex patch for women
449477
Procter &amp; Gamble will try today to persuade a federal advisory panel to recommend approval of the first drug, a testosterone patch worn on the abdomen, to increase a woman&#39;s sex drive.
672011
WASHINGTON - A federal scientific advisory panel meets Thursday to consider whether to recommend that a skin patch to enhance women&#39;s desire for sex should be licensed as a new drug.
329068
Women who were counting on Procter and Gambleâs new drug, Intrinsa, to spice up their sex lives will have to wait a little longer.
46540
WASHINGTON Dec 3, 2004 - In a move that could chill excitement about experimental drugs to treat female sexual dysfunction, federal advisers refused to endorse a new testosterone patch for women.
507550
US regulatory reviewers on Wednesday said it was unclear if Procter &amp; Gamble Co.&#39;s testosterone patch for boosting sexual desire in women produces meaningful benefit or is safe over the long term.
655423
Women may have to wait for years before a Procter &amp; Gamble testosterone patch being touted as the viagra for women becomes approved for the market.
603707
U.S. regulatory reviewers on  Wednesday said it was unclear if Procter & Gamble Co.'s PG.N  testosterone patch for boosting sexual desire in women produces  meaningful benefit or is safe over the long term.
37763
The US Food and Drug Administration (FDA) announced on Monday that Mifepristoneâs label will be changed to acknowledge that there are risks associated with any abortion, and that physicians prescribing the drug should instruct their patients to contact
612334
GAITHERSBURG, Md.  - Procter & Gamble Co.'s  testosterone patch needs to undergo more study to identify  potential, long-term safety risks before it could be approved,  a U.S. advisory panel ruled on Thursday.
667027
Menâs Fitness, Us Weekly and In Touch defended themselves against accusations last week that they had doctored their covers.
376124
Procter &amp; Gamble Co.&#39;s testosterone patch for boosting female sex drive needs longer-term testing for serious side effects before it can win approval, a US advisory panel unanimously ruled on Thursday.
471279
The Thursday night rejection of Proctor &amp; Gamble&#39;s (PG:NYSE - news - research) female testosterone sex-drive patch Intrinsa by a Food and Drug Administration advisory panel will almost certainly delay efforts by BioSante to develop its own product, a
327247
NEW YORK: A regulatory setback for Procter &amp; Gamble&#39;s patch to boost women&#39;s sex drive has enhanced investor interest in another therapy for female sexual dysfunction being developed by Vivus, the company&#39;s chief executive said.
2904
Measures to protect female patients from being sexually abused by doctors should be strengthened, a report says.
343005
A regulatory panel&#39;s Thursday decision not to recommend approval of Proctor &amp; Gamble Co.&#39;s sex-drive patch for women slammed shares of BioSante Pharmaceuticals Inc.
562225
Protecting the rights of women is a matter of fairness, social stability and public health. Improving the overall societal treatment of women and girls is one way to control the AIDS epidemic worldwide.
354947
A hormone patch that works to restore a woman&#39;s sex drive should not be approved until more studies are completed to determine the drug&#39;s risks, federal health advisers said Thursday.